IL83586A - Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them - Google Patents
Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing themInfo
- Publication number
- IL83586A IL83586A IL83586A IL8358687A IL83586A IL 83586 A IL83586 A IL 83586A IL 83586 A IL83586 A IL 83586A IL 8358687 A IL8358687 A IL 8358687A IL 83586 A IL83586 A IL 83586A
- Authority
- IL
- Israel
- Prior art keywords
- hexahydroarylquinolizines
- spirocondensed
- peripheral
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 title 1
- 125000004103 aminoalkyl group Chemical group 0.000 title 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 title 1
- 230000002093 peripheral effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 108020004101 alpha-2 Adrenergic Receptor Proteins 0.000 abstract 1
- 102000015006 alpha2-adrenergic receptor activity proteins Human genes 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US90148586A | 1986-08-28 | 1986-08-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL83586A0 IL83586A0 (en) | 1988-01-31 |
| IL83586A true IL83586A (en) | 1991-12-15 |
Family
ID=25414273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL83586A IL83586A (en) | 1986-08-28 | 1987-08-19 | Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0259092B1 (de) |
| JP (1) | JP2582799B2 (de) |
| KR (1) | KR880002869A (de) |
| AT (1) | ATE78482T1 (de) |
| AU (1) | AU597412B2 (de) |
| CA (1) | CA1288435C (de) |
| DE (1) | DE3780542T2 (de) |
| DK (1) | DK447387A (de) |
| ES (1) | ES2044944T3 (de) |
| GR (1) | GR3005537T3 (de) |
| IL (1) | IL83586A (de) |
| NZ (1) | NZ221485A (de) |
| PT (1) | PT85593B (de) |
| ZA (1) | ZA876400B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4942235A (en) * | 1989-03-16 | 1990-07-17 | Merck & Co., Inc. | Process for certain (2R-trans)hexahydroaroquinolizines |
| US5229387A (en) * | 1991-09-20 | 1993-07-20 | Syntex (U.S.A.) Inc. | Decahydro-8H-isoquino[2,1-g][1,6]naphthyridine and decahydrobenzo[a]pyrrolo [2,3-e]quinolizine derivatives |
| FR2744451B1 (fr) * | 1996-02-01 | 1998-04-24 | Pf Medicament | Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique |
| US6141745A (en) * | 1998-04-30 | 2000-10-31 | Advanced Micro Devices, Inc. | Functional bit identifying a prefix byte via a particular state regardless of type of instruction |
| FI126838B (en) | 2014-12-16 | 2017-06-15 | Vetcare Oy | Process for the preparation of spirocyclic substituted benzofuroquinolizines |
| FI131529B1 (en) | 2024-01-16 | 2025-06-11 | Vetcare Oy | Process for the racemization of benzofuroquinolizines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1435573A (en) * | 1973-05-25 | 1976-05-12 | Wyeth John & Brother Ltd | Indoloquinolizines |
| GB2106909B (en) * | 1981-10-07 | 1984-09-19 | Wyeth John & Brother Ltd | Benzoquinolizines |
| IE57014B1 (en) * | 1983-03-25 | 1992-03-11 | Wyeth John & Brother Ltd | Benzoquinolizines |
| ES8609323A1 (es) * | 1984-02-02 | 1986-07-16 | Merck & Co Inc | Un procedimiento para la preparacion de hexahidro-arilquinolizinas sustituidas. |
| NZ216283A (en) * | 1985-06-03 | 1989-10-27 | Merck & Co Inc | Hexahydro arylquinolizine derivatives and pharmaceutical compositions |
-
1987
- 1987-08-18 NZ NZ221485A patent/NZ221485A/en unknown
- 1987-08-19 AU AU77205/87A patent/AU597412B2/en not_active Ceased
- 1987-08-19 IL IL83586A patent/IL83586A/xx not_active IP Right Cessation
- 1987-08-26 PT PT85593A patent/PT85593B/pt not_active IP Right Cessation
- 1987-08-26 AT AT87307541T patent/ATE78482T1/de active
- 1987-08-26 CA CA000545453A patent/CA1288435C/en not_active Expired - Lifetime
- 1987-08-26 DE DE8787307541T patent/DE3780542T2/de not_active Expired - Fee Related
- 1987-08-26 EP EP87307541A patent/EP0259092B1/de not_active Expired - Lifetime
- 1987-08-26 ES ES87307541T patent/ES2044944T3/es not_active Expired - Lifetime
- 1987-08-27 ZA ZA876400A patent/ZA876400B/xx unknown
- 1987-08-27 DK DK447387A patent/DK447387A/da not_active Application Discontinuation
- 1987-08-28 KR KR870009444A patent/KR880002869A/ko not_active Withdrawn
- 1987-08-28 JP JP62214979A patent/JP2582799B2/ja not_active Expired - Lifetime
-
1992
- 1992-08-27 GR GR920401865T patent/GR3005537T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL83586A0 (en) | 1988-01-31 |
| NZ221485A (en) | 1991-04-26 |
| ATE78482T1 (de) | 1992-08-15 |
| EP0259092B1 (de) | 1992-07-22 |
| ZA876400B (en) | 1988-02-25 |
| DE3780542T2 (de) | 1993-01-07 |
| KR880002869A (ko) | 1988-05-12 |
| GR3005537T3 (de) | 1993-06-07 |
| DE3780542D1 (en) | 1992-08-27 |
| EP0259092A1 (de) | 1988-03-09 |
| DK447387D0 (da) | 1987-08-27 |
| AU597412B2 (en) | 1990-05-31 |
| PT85593A (en) | 1987-09-01 |
| PT85593B (pt) | 1990-05-31 |
| DK447387A (da) | 1988-02-29 |
| JP2582799B2 (ja) | 1997-02-19 |
| JPS63139183A (ja) | 1988-06-10 |
| AU7720587A (en) | 1988-03-03 |
| ES2044944T3 (es) | 1994-01-16 |
| CA1288435C (en) | 1991-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94040864A (ru) | Конденсированные индольные производные, их получение, фармацевтическая композиция | |
| KR890002030A (ko) | 메데토 미딘의 d 및 1 에난티오머, 그 분리 방법 및 이를 포함하는 제약학적 조성물 | |
| DE3779500D1 (de) | Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen. | |
| HU9203383D0 (en) | 2-amino-methyl-chromane derivatives and method for producing said compounds and pharmaceutical preparatives containing them | |
| IL104006A (en) | Azaheterocyclylmethyl-chromans their preparation and pharmaceutical compositions containing them | |
| FI961809A0 (fi) | Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit | |
| RU93004793A (ru) | Производные хиназолина, способ их получения, фармацевтическая композиция на их основе | |
| PL330207A1 (en) | Aryl-substituted cyclic amines as selective ligands of d 3 dopamine | |
| TNSN90021A1 (fr) | Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales | |
| FR2531950B1 (fr) | Derives d'amides d'acide o-amines, leur preparation, leur utilisation dans le traitement des affections du systeme nerveux central et des troubles cardiovasculaires, et compositions les contenant | |
| IL83586A (en) | Acylated aminoalkyl and hydroxyalkyl substituted spirocondensed hexahydroarylquinolizines and peripheral alpha2 adrenoceptor antagonist pharmaceutical compositions containing them | |
| ATE67756T1 (de) | N-substituierte 3-piperidin- oder 3pyridincarbons|uren und deren derivate. | |
| EP0554313A4 (en) | Disubstituted aryl compounds exhibiting selective leukotriene b 4? antagonist activity | |
| IL89736A0 (en) | Bicyclic amine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| DE69330150D1 (de) | Pharmazeutische Zusammensetzungen zur transdermalen Verabreichung von Melatonin und/oder seine Analoge | |
| IL104005A0 (en) | Piperidylmethyl-substituted chroman derivatives,their preparation and pharmaceutical compositions containing them | |
| ES2005042A6 (es) | Procedimiento de preparar derivados de aminoacidos que tienen actividad sobre el sistema nervioso central. | |
| IL109076A0 (en) | Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them | |
| ES8604597A1 (es) | Procedimiento de preparar compuestos tiopiranopirimidinicos farmacologicamente activos. | |
| ES557149A0 (es) | Un procedimiento para la preparacion de derivados peptidicos de histidinilprolinamida. | |
| IT1209276B (it) | Composizione farmaceutica per la somministrazione orale del metilestere dell'acido 13a-etil-2,3,5,6,12,13,13a,13b-ottaidro-12-idrossi1h-indolo-[3,2,1-de] pirido [3,2,1-ij] [1,5] naftiridina -12-carbossilico | |
| MA19881A1 (fr) | Procede de preparation de derives de spiro (2h-1,4-benzodioxepine-3 (5h) 4'-piperidine et -3'-pyrrolidine). | |
| DK0950053T3 (da) | Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater | |
| EP0202986A3 (en) | Use of "naftidrofuryl" in the treatment of neuropathies | |
| RU93029617A (ru) | Имидазопиридины, способ их получения, фармацевтическая композиция и способ ее получения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |